nad has been researched along with Carcinoma, Non-Small Cell Lung in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 9 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| He, P; Hou, Y; Li, N; Liu, Z; Yang, Y; Zhang, X | 1 |
| Boldrini, L; Bria, E; Chiappetta, M; Ciavarella, LP; Congedo, MT; Evangelista, J; Larici, A; Lococo, F; Margaritora, S; Nachira, D; Porziella, V; Sassorossi, C | 1 |
| Boldrini, L; Bria, E; Cesario, A; Charles-Davies, D; Chiappetta, M; Congedo, MT; Evangelista, J; Lococo, F; Margaritora, S; Massaccesi, M; Nachira, D; Porziella, V; Sassorossi, C; Sperduti, I; Valentini, V; Vita, E | 1 |
| Chen, L; Chen, S; Chen, W; Fu, W; Jiang, S; Jiang, Z; Li, D; Li, X; Ma, X; Pan, Y; Wang, Q; Xing, X; Xu, C; Zhang, L; Zhou, H | 1 |
| Adelmann, CH; Bar-Peled, L; Bardeesy, N; Carlin, A; de Groot, A; Dürr, BR; Fischer, H; Fisher, DE; Ge, M; Gohar, M; Haigis, MC; Harry, S; Hata, AN; Hayashi, M; Mostoslavsky, R; Papagiannakopoulos, T; Richter, M; Shi, L; Takahashi, M; Vijay, V; Vornbäumen, T; Wei, TY; Weiss-Sadan, T; Wolf, K; Yang, TY; Yao, CH; Zhang, J | 1 |
| Bey, EA; Boatman, MA; Carter, JH; Madajewski, B; Martinez, I | 1 |
| Ai, N; Chen, X; Ge, W; Hou, Y; Lu, JJ; Yu, J; Zhao, L; Zhong, B | 1 |
| Chen, T; Deng, Y; Fan, Q; Gao, J; Li, M; Li, X; Li, Z; Liu, G; Sun, L; Yao, F; Zeng, Z; Zhang, Z; Zhong, C | 1 |
| Krawic, C; Luczak, MW; Zhitkovich, A | 1 |
| Shao, B; Tian, L; Yan, Y; Zhou, W; Zhu, B | 1 |
| Adam, J; Ashworth, A; Bigot, L; Bouillaud, F; Chabanon, RM; Dorvault, N; Durand, S; Frankum, JR; Friboulet, L; Garrido, M; Krastev, DB; Kuo, MS; Lombès, A; Lord, CJ; Mardakheh, F; Morel, D; Olaussen, KA; Pierron, G; Pontoizeau, C; Postel-Vinay, S; Sarasin, A; Sauvaigo, S; Soria, JC; Souquère, S; Sourisseau, T; Touat, M | 1 |
| Belmont, LD; DelNagro, C; Durieux, JK; Elkins, K; Jackson, PK; Kwong, M; Lee, L; Liang, X; Liederer, BM; O'Brien, T; Oeh, J; Sampath, D; Tremayne, J; Xiao, Y; Yang, LX | 1 |
| Avizonis, D; Bramoullé, A; Bridon, G; Chan, M; Gravel, M; Roulston, A; Shore, GC | 1 |
| Hong, KM; Jang, H; Kang, JH; Kim, SY; Lee, C; Lee, JS; Lee, SH; Nam, B; Seong, TW; Son, J | 1 |
| Cheng, X; Hao, H; Li, Q; Liu, F; Liu, H; Wang, G; Wang, H; Xing, R; Ye, H; Zhao, M | 1 |
| Cheng, XF; Hao, HP; Li, QR; Liu, HY; Wang, GJ | 1 |
| Ahn, HS; Ahn, JH; Hong, D; Hong, KM; Jang, H; Kang, JH; Kim, SY; Lee, C; Lee, CH; Lee, JH; Lee, JS; Lee, SH; Seong, TW | 1 |
| Hong, D; Hong, KM; Kang, JH; Kim, SY; Lee, JS; Lee, SH; Son, J; Song, J | 1 |
| Beall, HD; Gibson, NW; Mulcahy, RT; Ross, D; Siegel, D; Traver, RD | 1 |
| Martin-Mateo, MC; Molpeceres, LM; Ramos, G | 1 |
| Begleiter, A; Fiterman, DJ; Fourie, J; Guziec, F; Guziec, L; Monterrosa, C; Oleschuk, CJ | 1 |
21 other study(ies) available for nad and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine/glutamate/α-KG metabolic axis.
Topics: Adenosine Triphosphate; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Glutamic Acid; Glutamine; Humans; Ketones; Lung Neoplasms; Mice; Mitochondria; NAD | 2022 |
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Male; NAD; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Treatment Outcome | 2022 |
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; NAD; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Retrospective Studies | 2022 |
CRISPR-based DNA methylation editing of NNT rescues the cisplatin resistance of lung cancer cells by reducing autophagy.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cisplatin; DNA; DNA Methylation; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; NAD; NADP Transhydrogenases; Sirtuin 1 | 2023 |
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; NAD; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction | 2023 |
NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer.
Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; NAD; NAD(P)H Dehydrogenase (Quinone); NADH, NADPH Oxidoreductases; Quinones | 2023 |
Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Ferroptosis; Humans; Lung Neoplasms; NAD; NAD(P)H Dehydrogenase (Quinone); Reactive Oxygen Species; RNA, Small Interfering; Zebrafish | 2023 |
Nicotinamide adenine dinucleotide kinase promotes lymph node metastasis of NSCLC via activating ID1 expression through BMP pathway.
Topics: Carcinoma, Non-Small-Cell Lung; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Protein 1; Lung Neoplasms; Lymphatic Metastasis; NAD; Signal Transduction | 2023 |
NAD
Topics: A549 Cells; Adenocarcinoma, Bronchiolo-Alveolar; Amino Acids, Dicarboxylic; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Hypoxia; Cell Proliferation; Cytokines; Fibroblasts; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; L-Lactate Dehydrogenase; Lung Neoplasms; NAD; Nicotinamide Phosphoribosyltransferase; Signal Transduction; Transfection | 2021 |
Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.
Topics: Aged; Asian People; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Down-Regulation; Ethnicity; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lysine; Male; Middle Aged; NAD; Neoplasm Metastasis; Prognosis; RNA, Messenger; Sirtuins; Survival Analysis | 2018 |
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cytokines; DNA Repair; DNA-Binding Proteins; Endonucleases; Humans; Lung Neoplasms; Mice; Mice, Nude; NAD; Neoplasm Proteins; Neoplasms, Experimental; Nicotinamide Phosphoribosyltransferase | 2018 |
Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Heterografts; Humans; Lung Neoplasms; Mice, Nude; NAD; Pentosyltransferases; Pyrazoles; Sulfones | 2013 |
Synergy between the NAMPT inhibitor GMX1777(8) and pemetrexed in non-small cell lung cancer cells is mediated by PARP activation and enhanced NAD consumption.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytokines; DNA Repair; Drug Synergism; Gene Expression Regulation, Neoplastic; Glutamates; Guanidines; Guanine; Humans; Mice; NAD; Nicotinamide Phosphoribosyltransferase; Pemetrexed; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Transcriptional Activation; Xenograft Model Antitumor Assays | 2014 |
Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion.
Topics: Action Potentials; Adenosine Triphosphate; Aldehyde Dehydrogenase; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytosol; Female; Gossypol; Humans; Lung Neoplasms; Malates; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; NAD; NADP; Neoplasm Transplantation; Oxidative Phosphorylation; Oxidoreductases Acting on CH-NH Group Donors; Phenformin; RNA, Small Interfering | 2016 |
De-novo NAD+ synthesis regulates SIRT1-FOXO1 apoptotic pathway in response to NQO1 substrates in lung cancer cells.
Topics: A549 Cells; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Forkhead Box Protein O1; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Lung Neoplasms; Mice; Mice, Nude; NAD; NAD(P)H Dehydrogenase (Quinone); Neoplasm Transplantation; Oxidative Stress; Oxygen; Signal Transduction; Sirtuin 1; Tryptophan | 2016 |
NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells.
Topics: Abietanes; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytokines; Enzyme Inhibitors; Humans; NAD; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Nicotinamide Phosphoribosyltransferase | 2016 |
Aldehyde dehydrogenase is used by cancer cells for energy metabolism.
Topics: Adenosine Triphosphate; Aldehyde Dehydrogenase; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Energy Metabolism; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; NAD; Protein Isoforms | 2016 |
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Topics: A549 Cells; Adenosine Triphosphate; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Cell Survival; Cytosol; Drug Synergism; Fluorouracil; Gene Knockdown Techniques; Glutamic Acid; Glutaminase; Glutamine; Lung Neoplasms; Malates; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; NAD; Oxidation-Reduction; Sulfides; Thiadiazoles; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2016 |
Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
Topics: Aerobiosis; Animals; Antineoplastic Agents; Biotransformation; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Chromatography, High Pressure Liquid; DNA Damage; DNA, Neoplasm; Escherichia coli; Humans; Kinetics; Lung Neoplasms; Mitomycin; NAD; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Transfection; Tumor Cells, Cultured | 1994 |
Assay for erythrocyte superoxide dismutase activity in patients with lung cancer and effects on pollution and smoke trace elements.
Topics: Adenocarcinoma; Aged; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Environmental Pollutants; Erythrocytes; Female; Free Radicals; Humans; Lung Neoplasms; Male; Middle Aged; NAD; Neoplasm Staging; Oxidation-Reduction; Spectrophotometry, Ultraviolet; Superoxide Dismutase; Tobacco Smoke Pollution; Trace Elements | 1997 |
The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Topics: Antineoplastic Agents; Benzoquinones; Biotransformation; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; NAD; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |